Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects.

Abstract

BACKGROUND:

Exercise training is well established as the most effective way to enhance muscle performance and muscle building. The composition of skeletal muscle fiber type affects systemic energy expenditures, and perturbations in metabolic homeostasis contribute to the onset of obesity and other metabolic dysfunctions. Long noncoding RNAs (lncRNAs) have been demonstrated to play critical roles in diverse cellular processes and diseases, including human cancers; however, the functional importance of lncRNAs in muscle performance, energy balance, and obesity remains elusive. We previously reported that the lncRNA H19 regulates the poly-ubiquitination and protein stability of dystrophin (DMD) in muscular dystrophy.

METHODS:

Here, we identified mouse/human H19-interacting proteins using mouse/human skeletal muscle tissues and liquid chromatography-mass spectrometry (LC-MS). Human induced pluripotent stem-derived skeletal muscle cells (iPSC-SkMC) from a healthy donor and Becker Muscular Dystrophy (BMD) patients were utilized to study DMD post-translational modifications and associated proteins. We identified a gain-of-function (GOF) mutant of H19 and characterized the effects on myoblast differentiation and fusion to myotubes using iPSCs. We then conjugated H19 RNA gain-of-function oligonucleotides (Rgof) with the skeletal muscle enrichment peptide agrin (referred to as AGR-H19-Rgof) and evaluated AGR-H19-Rgof's effects on skeletal muscle performance using wild-type (WT) C57BL/6 J mice and its anti-obesity effects using high-fat diet (HFD)- and leptin deficiency-induced obese mouse models.

RESULTS:

We demonstrated that both human and mouse H19 associated with DMD and that the H19 GOF exhibited enhanced interaction with DMD compared to WT H19. DMD was found to associate with serine/threonine-protein kinase MRCK alpha (MRCKα) and α-synuclein (SNCA) in iPSC-SkMC derived from BMD patients. Inhibition of MRCKα and SNCA-mediated phosphorylation of DMD antagonized the interaction between H19 and DMD. These signaling events led to improved skeletal muscle cell differentiation and myotube fusion. The administration of AGR-H19-Rgof improved the muscle mass, muscle performance, and base metabolic rate of WT mice. Furthermore, mice treated with AGR-H19-Rgof exhibited resistance to HFD- or leptin deficiency-induced obesity.

CONCLUSIONS:

Our study suggested the functional importance of the H19 GOF mutant in enhancing muscle performance and anti-obesity effects.

• Authors: Yajuan Li, Yaohua Zhang, Qingsong Hu, Sergey D Egranov, Zhen Xing, Zhao Zhang, Ke Liang, Youqiong Ye, Yinghong Pan, Sujash S Chatterjee, Brandon Mistretta, Tina K Nguyen, David H Hawke, Preethi H Gunaratne, Mien-Chie Hung, Leng Han, Liuqing Yang, Chunru Lin
• Journal: Genome medicine (Genome Med) Vol. 13 Issue 1 Pg. 137 (08 28 2021) ISSN: 1756-994X [Electronic] England
• PMID: 34454586 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
• Copyright: © 2021. The Author(s).

Chemical References

• Biomarkers
• Carrier Proteins
• DMD protein, human
• Dystrophin
• H19 long non-coding RNA
• RNA, Long Noncoding

Topics

• Animals
• Biomarkers
• Carrier Proteins
• Cell Differentiation (genetics)
• Cells, Cultured
• Disease Management
• Disease Models, Animal
• Disease Susceptibility
• Dystrophin (genetics, metabolism)
• Fluorescent Antibody Technique (methods)
• Gain of Function Mutation
• Genetic Therapy
• Humans
• Immunohistochemistry
• Induced Pluripotent Stem Cells (metabolism)
• Mice
• Mice, Knockout
• Muscle Development (genetics)
• Muscle, Skeletal (metabolism)
• Muscular Dystrophy, Duchenne (genetics, metabolism, therapy)
• Obesity (diagnosis, etiology, metabolism, therapy)
• Phosphorylation
• Protein Binding
• RNA, Long Noncoding (genetics)